Xipamide
Spécifications
14293-44-8Numéro CAS
238-216-4Numéro CE
4-chloro-N-(2,6-dimethylphenyl)-2-hydroxy-5-sulfamoylbenzamideNom IUPAC
C15H15ClN2O4SFormule chimique
354.8 g/molMasse molaire
XIPAMIDE; 14293-44-8; Diurexan; Xipamid; Xipamida; Xipamidum; BE-1293; MJF-10938; DTXSID5023744; MJF 10,938; 4-Chloro-5-sulfamoyl-2',6'-salicyloxylidide; Benzamide, 5-(aminosulfonyl)-4-chloro-N-(2,6-dimethylphenyl)-2-hydroxy-; 4S9EY0NUEC; DTXCID503744; RefChem:195367; C03BA10; 238-216-4; 4-chloro-N-(2,6-dimethylphenyl)-2-hydroxy-5-sulfamoylbenzamide; Aquaphor; Diurex (lacer); Aquaphor (diuretic); C15H15ClN2O4S; Be 1293; MFCD00865927; 2',6'-Salicyloxylidide, 4-chloro-5-sulfamoyl-; 4-Chlor-5-sulfamoyl-2',6'-salicyloxylidid; Benzamide,5-(aminosulfonyl)-4-chloro-N-(2,6-dimethylphenyl)-2-hydroxy-; Xipamide (USAN); NCGC00182543-01; Aquaphoril; XIPAMIDE [USAN]; Zipix; Chronexan; Xipamidum [INN-Latin]; Xipamida [INN-Spanish]; Xipamide [USAN:INN:BAN]; CAS-14293-44-8; EINECS 238-216-4; UNII-4S9EY0NUEC; MJF 10938; BRN 2778357; Lumitens; BEI-1293; 4-Chlor-5-sulfamoyl-2',6'-salicyloxylidid [German]; Xipamide (Standard); XIPAMIDE [INN]; XIPAMIDE [MI]; 4-chloro-N-(2,6-dimethylphenyl)-2-hydroxy-5-sulfamoyl-benzamide; XIPAMIDE [MART.]; XIPAMIDE [WHO-DD]; SCHEMBL43532; CHEMBL517199; GTPL7900; orb1307598; SCHEMBL29377965; CHEBI:135499; GLXC-07944; HMS5084I21; HY-W042301R; MSK10704; Tox21_112975; 5-(Aminosulfonyl)-4-chloro-N-(2,6-dimethylphenyl)-2-hydroxybenzamide; AC-911; s5076; 5-(Aminosulfonyl)-4-chloro-N-(2,6-dimethylphenyl)-2-hydroxy-benzamide; AKOS015889012; Tox21_112975_1; CCG-268092; CS-W023041; DB13803; DS-1401; FX28740; HY-W042301; NCGC00182543-02; NS00008537; X0079; 4-Chloro-5-sulfamoyl-2',6'-salicyloxilidide; D06341; SBI-0654188.0001; T17266; F093388; Q600951; BRD-K27393415-001-01-0; 4-Chloro-N-(2,6-dimethylphenyl)-2-hydroxy-5-sulphamoylbenzamide; 4-Chloro-N-(2 pound not6-dimethylphenyl)-2-hydroxy-5-sulfamoylbenzamide; 5-(Aminosulfonyl)-4-chloro-N-(2,6-dimethylphenyl)-2-hydroxybenzamide #Synonymes
